WORLAND STEPHEN T 4
4 · eFFECTOR Therapeutics, Inc. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2023-11-15$0.50/sh+5,979$2,973→ 267,204 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.